chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported. On 23-MAR-2017, the patient was vaccinated with an expired dose of PNEUMOVAX23 injection (lot # L003227 with expiration date at 13-OCT-2016; dose, route of administration and anatomical location were not reported) for prophylaxis. There were no side effects reported. No product quality complaint (PQC) was involved. Additional information has been requested.
24/7 Head burning sensation with intermittent tightening sensation; brain fog;  leg weakness and heaviness ;  nervousness;  high anxiety  Similar report -Adverse event VAERS ID#- 761392-1 ending in Suicide(7/10/18).    Similar reported symptoms.   [Sep 2019   LOT: NDC 49281-405-65 Sanofi Pasteur]My double Senior Dose.  Husband injected just before me, using same lot, same nurse.
Very little swelling of the tongue; Aching and arm hurts; Headache; This spontaneous case was reported by a consumer and describes the occurrence of SWOLLEN TONGUE (Very little swelling of the tongue), PAIN IN EXTREMITY (Aching and arm hurts) and HEADACHE (Headache) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced SWOLLEN TONGUE (Very little swelling of the tongue), PAIN IN EXTREMITY (Aching and arm hurts) and HEADACHE (Headache). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 05-Feb-2021, SWOLLEN TONGUE (Very little swelling of the tongue), PAIN IN EXTREMITY (Aching and arm hurts) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication list was not provided.
Left side lump on his upper thigh just noticed yesterday. Here for lump of skin, thinks its only been there a day or so. Lump on left upper thigh. Doesn't seem to be causing pain. No fever, no change in appetite, playful as usual. No other rash or lump. He did have vaccines x 4 at his recent visit for WCC on 7/25/16. No other c/o.
This spontaneous report as received from a consumers mother refers to a 4 year old male patient with allergic to peanuts, molds and pollen. Patients pertinent medical history was none. On 26-FEB-2013, the patient was vaccinated with a dose of (Merck) VARIVAX (lot number, expiry date and route were not reported). 0.5 ml (reported as standard dose). Concomitantly the patient also received diphtheria toxoid, pertussis acellular vaccine (unspecified), tetanus toxoid on 26-FEB-2013. The patient had no fever, no vomiting after vaccination. On 05-MAR-2013 (reported as 7 days after vaccination), the patient has stinky egg smelling burps and similar smelling diarrhea which lasted for 12 hours. On 06-MAR-2013 (reported as the morning after diarrhea started), the patient experienced leg pain which had worsened to the point that he was not able to walk. Blood and urine testing performed on an unspecified date in March 2013, diagnosed with possible viral toxic synovitis. The patient sought medical attention and was treated with ibuprofen. On 05-MAR-2013, the events stinky egg smelling burps and similar smelling diarrhea were resolved. The reporter reported that the leg pain dissipated over 3 days moving from being unable to walk, moving through shuffling motions, regaining full mobility although rigid, and finally full recovery. Approximately on an unknown date in March 2013,the event a leg pain worsened to the point that he was not able to walk was reported as recovered/resolved. The outcome of diagnosed with possible viral toxic synovitis was unknown. Additional information is not expected.
Pt began having itching and hives appx 1hr after vaccine was administered. At home took 100mg BENADRYL and was given 1 dose of EPIPEN in clinic. Evaluated by Medical Director and transferred to ER for further evaluation/treatment.
Localized indurated reaction at imm site starting 8 days after vaccination. Tx with ice, topical corticosteroids. NSAIDS.
Left leg, lg. local reaction; rash; heat to injection site; inflamed; knot, left leg edema.
fatigue; 102 fever; chills; This is a spontaneous report from a contactable consumer. A 70-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EH9899), via an unspecified route of administration in left arm on 29Dec2020 15:00 at a single dose for covid-19 immunization. Administration was done in a Nursing Home/Senior Living Facility. The patient's medical history was not reported. Concomitant medication included trazodone and methimazole. On 01Jan2021 at 03:00, the patient experienced fatigue, 102 fever and chills. The outcome of the events was not recovered. There was no treatment received for the events. The consumer considered the events as non-serious. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not been tested for COVID-19.
arm red; itchiness in the area where she got the vaccine; it's like inflammed; it felt different; fever; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (it felt different), ERYTHEMA (arm red), VACCINATION SITE PRURITUS (itchiness in the area where she got the vaccine), PYREXIA (fever) and VACCINATION SITE SWELLING (it's like inflammed) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014C21A and 0-14C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-May-2021, the patient experienced FEELING ABNORMAL (it felt different) and PYREXIA (fever). On 29-May-2021, the patient experienced ERYTHEMA (arm red), VACCINATION SITE PRURITUS (itchiness in the area where she got the vaccine) and VACCINATION SITE SWELLING (it's like inflammed). The patient was treated with PARACETAMOL (TYLENOL) for Symptomatic treatment, at a dose of 1 dosage form. On 29-May-2021, PYREXIA (fever) had resolved. At the time of the report, FEELING ABNORMAL (it felt different), ERYTHEMA (arm red), VACCINATION SITE PRURITUS (itchiness in the area where she got the vaccine) and VACCINATION SITE SWELLING (it's like inflammed) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product was not provided by the reporter.  Action taken with mRNA-1273 in response to the event was not applicable.   The patient had felt better a fewdays after the adverse events were reported and thus had no more info to provide.   This case was linked to MOD-2021-190170, MOD-2021-190170 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Follow up received on 14-JUN-2021 had information about onset date and outcome of events.
Past lot that had also been expired that was administered to Patients; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Past lot that had also been expired that was administered to Patients) and NO ADVERSE EVENT (No adverse event) in a 69-year-old male patient who received mRNA-1273 (Spikevax) (batch no. O70H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Past lot that had also been expired that was administered to Patients) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Past lot that had also been expired that was administered to Patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Past lot that had also been expired that was administered to Patients).    NDCID number was reported.  Patient age was reported as 69 years 8 months.  Concomitant product use was not provided by the reporter.  It was reported that also another lot of vaccines lot number 065F21A was also expired and administered to patient and lot number O70H21A this was administered to patient in between 08-Apr-2022 and 15-Dec-2022.  Treatment information was not provided.
After the second dose 09/07/21 I started with a rash on both arms. A lot of blisters covered the top of my hands and arms. three days later I had a bad cold.
Soreness at the site of injection; Redness at the site of injection; Fluad was given to under the age of 65; This is a non-serious spontaneous case, initially received from pharmacist on 05-Dec-2018, concerning a 30-year-old, adult, female patient.  On 25-Oct-2018, the patient (under 65 years) was administered Fluad (TIV) [influenza vaccine, inactivated influenza virus surface antigen (subunit), egg-derived, MF59, dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch number: 250794 and expiry date: 30-Apr-2019] for active immunization against influenza (explicitly coded as inappropriate age at vaccine administration).  On the same day, after vaccination, the patient experienced soreness and redness at the injection site for 5 days. It was reported that no treatment was required.  The outcome of the events was recovered on 30-Oct-2018.  This case is linked to 201804954 due to same reporter.  Follow up report received from the pharmacist on 07-Jan-2019: The reporter did not give the permission to contact the patient and hence no patient information was provided. Added reference number (Med info number: SEQ19-00117) in the additional information section. No changes were made in the narrative.; Reporter's Comments: A 30-year-old female patient (under 65 years) was administered Fluad (TIV) (as inappropriate age at vaccine administration) and developed pain injection site and injection site redness on the same day after vaccination. The company assessed the causality of the events (pain injection site and injection site redness) as related to suspect vaccine due to plausible temporal relationship between the events and suspect vaccine and the causality of the event (inappropriate age at vaccine administration) as not related to suspect vaccine due to accidental nature of the event.
This spontaneous report as received from a Licensed Practical Nurse refers to a patient of unknown age. On 15-MAY-2014 the patient was vaccinated with an expired dose of PNEUMOVAX 23 (lot # H014653; expiry date: 19-APR-2014). Dose and route were not reported. No adverse effect was reported. Additional information has been requested.
Pt received the second shot 16 days after the first COVID shot, which is one day too early. Pt experienced fatigue and headache for 2 days and both of those have since resolved.
Febrile convulsion on 5/15/06. She was seen at ER and released.
2nd dose pfizer vaccine was given to patient on 07/07/202. We found out on 07/09/2021 vaccine was stored outside the recommended 31 day expiration window. We reached out to pt on 07/10/21. Patient will return to the pharmacy on 07/15/21 to get the 2nd dose again.
Flu vaccine on 10/22/22. I informed them I have egg allergies/assured by the center they had Flu vaccines for egg allergies recipients. On 10/23/22 PM, I started to have pain in both hips. I used warm compressors and motrin/ Right Hip felt better in about 2 days, but lef hip pain continued/ also pain in left side of Coccyx if I cough or sneeze/ pain sudden, intermittent/radiated down left leg/felt like sudden electric shocks. Weakness started in left leg that still exist today. I was seen by Dr. 10/27 . Spine hip xrays done, no fractures/Referred to orthopedics. Saw Dr. Spine Orthopedics/ Xray of Coccyx done 11/4/2022./ Leg and Hip MD Appt 11/9/22/ Referral -Physical Therapy-Appt 11/21/22
Chills-sore throat-cough-wheezing and some fast heart beat-was all gone in 3 days, doing fine now.
Body aches; Chills; Fever; Extreme fatigue; Nausea; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep6955), via an unspecified route of administration in the left arm on 29Mar2021 at 12:45 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included anemia and the patient had a history of allergy to sulfur medication, garlic and dairy intolerance. Concomitant medications included mirtazapine (MANUFACTURER UNKNOWN) and acetylsalicylic acid, caffeine, paracetamol (EXCEDRIN) for an unspecified indication from an unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  On 30Mar2021 at 00:00, the patient experienced flu like symptoms such as chills, fever, body aches, extreme fatigue, nausea and headache. The events did not result in doctor or other healthcare professional office/clinic, and emergency room/department or urgent care. No therapeutic measures were taken for the events. The clinical outcome of the events chills, fever, body aches, extreme fatigue, nausea and headache was resolved on an unknown date in 2021.   No follow-up attempts are possible. No further information is expected.
After both of my shots, my blood glucose numbers have gone up. In particular after the 2nd one. My fasting glucose has jumped almost 50 points. And I am having random other high numbers.  Also, my period was late and heavy after the first shot  and is now late again.   And I have a had a mild headache with both shots lasting weeks not days.
This spontaneous report as received from a nurse refers to a patients of unknown age and gender. A nurse reported that on unknown date an unspecified number of patients have been administered doses of (Oka/Merck) VARIVAX (lot #, expiration date, dose and route were not reported). It was reported that (Oka/Merck) VARIVAX was stored at a 0 Celsius degree for 24 hours. No adverse effects reported. Additional information has been requested. This is one of several reports received from the same reporter.
This spontaneous report as received from a medical assistant refers to an adult patient of unknown gender who on 22-APR-2015, was vaccinated with a dose of GARDASIL (lot # K006960, expiration date: not reported) which was exposed to 47 degree C for 15 hours. No adverse effects had been observed or reported. This is one of several reports from the same reporter. Additional information has been requested.
Pt is a 31 yo female G3P0020 37w3d with an estimated delivery date of 6/5/21. She is fully vaccinated against COVID-19 with Pfizer vaccination first dose on 3/17, second dose on 4/7. On 5/18, she presents to this institution for a scheduled ECV. While admitted, she undergoes standard inpatient COVID-19 testing, which results positive. Pt was asymptomatic and vitals WNL. After extensive discussion with physician, pt chooses not to proceed with ECV on 5/18. Unclear if COVID+ diagnosis played a role in decision. Pt advised to quarantine for 10 days.
Have experienced shortness of breath; Increased wheezing; Headaches; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Apr2021 at 13:00 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included salbutamol (VENTOLIN) and fexofenadine hydrochloride (ALLEGRA); for unknown indications, from an unknown date and unknown if ongoing. The patient previously took azithromycin (MANUFACTURER UNKNOWN) on unknown date for unknown indication and experienced drug allergy. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 27Apr2021 at 12:00, the patient experienced shortness of breath, increased wheezing and headaches. The patient did not see shortness of breath on the side effects so he wanted to make it noted. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events shortness of breath, increased wheezing and headaches was recovering at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Indication for use in the case: Treatment of COVID-19; Indication for use in the case: Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Physician).  A 73-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 21Dec2020 as dose 1, single (Lot number: EH9899), in right arm, on 11Jan2021 as dose 2, single (Lot number: EK4176), in right arm, on 18Aug2021 as dose 3 (booster), single (Lot number: FC3180), in right arm and on 01Feb2022 as dose 4 (booster), single (Lot number: FK9729) at the age of 72 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Variable Immunodeficiency Disorder" (unspecified if ongoing), notes: On weekly immunoglobulin; "Known allergies" (unspecified if ongoing). Concomitant medication(s) included: ELIQUIS oral. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 16May2022, outcome "not recovered" and all described as "Indication for use in the case: Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (30May2022) Negative, notes: had negative antigen test on 30May22; (06Jun2022) Positive, notes: Still positive on 06Jun22 and symptoms still present. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: Patient received Eliquis orally as medication in 2weeks. Rebound infection. Initial symptoms on 16May2022. Started Paxlovid started afternoon of 17May2022 and completed on morning of 22May2022 as treatment for covid-19. Symptoms improved over the next week and had negative antigen test on 30May2022. Recurrent cough, diarrhea, fatigue on 02Jun2022 and antigen test again positive. Still positive on 06Jun2022 and symptoms still present.; Sender's Comments: Based on the current limited available information, a possible contributory role of the suspect product BNT162b2 to the development of events vaccination failure and COVID-19 cannot be excluded.  The case will be reassessed if additional information becomes available.
Systemic: Tingling (specify: facial area, extemities)-Mild, Additional Details: pt stated left hand tingling   kept pt for 30 minutes when left she stated she felt much better  hardly noticeable   called at end of shift   left message
On the day after the booster shot, 10/14, I had a low fever (around 100) and felt tired and achy--all of which was in line with how I'd felt following the first two Pfizer shots I'd had in March and April 2021. But on 10/15, I started having diarrhea, and by 10/17, I had 20 episodes in a single day. Despite not eating and then moving to the BRAT diet, I averaged about 10 episodes/day of diarrhea for 3 weeks. I lost 12 pounds and bloodwork and stomach imaging revealed no other problems.  11/8 was my first day without diarrhea--and from there I improved rapidly. I'm seemingly fine now.
Monday morning I started to feel dizzy and nauseous; Monday morning I started to feel dizzy and nauseous; headache started almost immediately after receiving the vaccine; This is a spontaneous report from a contactable consumer (Patient) reporting for herself. A 36-years-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EW0217; Expiration date was not reported), via an unspecified route of administration, in Left Arm on 03Jun2021 15:00 (at the age of 36-years-old) as DOSE 1, SINGLE for covid-19 immunisation at Pharmacy or Drug store. The patient medical history included depression, panic disorder, injury, stress (trauma and stressor related disorder), asthma, glucose tolerance impaired (prediabetes), obesity from an unknown date and unknown if ongoing. The patient had no known allergies and the patient did not receive other vaccine in four weeks, The patient was not diagnosed covid prior vaccination, The patient had not been tested for covid, post vaccination. The patient concomitant medications included buspirone hydrochloride (BUSPAR); fluoxetine hydrochloride (PROZAC); loratadine (LORATADINE); fluticasone propionate (FLONASE [FLUTICASONE PROPIONATE]) taken for an unspecified indication, start and stop date were not reported. The patient experienced headache started almost immediately after receiving the vaccine on 03Jun2021, Monday morning patient started to feel dizzy and nauseous on 07Jun2021 07:00. The patient did not received treatment for the events. Clinical outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected
This is actually an administration error. Typing up patient's flu shot on 9/15/20 i realized that I had given patient a egg free flu shot (flublok)(on 9/14/20 clinic) due to his discovered allergy to eggs at the clinic when i asked him even though his sheet stated he wasnt. Flublok was chosen to minimize his reaction to the flu shot due to his potential egg allergy. When entering in his RX on 9/15 I noticed that Flublok is only indicated for ages 18+. upon doing research, newer studies show that Flublok is actually just as safe and efficacious as fluarix in ages 7-17 so there was minimal need for concern. I spoke with patient's mom on 9/15/20 at 5:00 PM and explained the situation and asked how patient was doing. Both of her sons had gotten the flu shot that day and both were feeling a little under the weather but besides that they were fine. She was understanding of the situation and thanked me for explaining and telling her what i had discovered. I told her that I would let the provider know as well since the vaccine was technically off label for his age group still. I called Dr's office on 9/15/20 at 5:08 pm and spoke with his nurse and explained the entire situation again. The nurse was ok with what had happened and told me she would pass on the information to Dr as well so that he could be made aware and document this as well. I will make a dispensing error report and VAERS form tonight just to cover what happened and keep this documented. 9/15/20 at 5:19pm